Myocardial Injury Detection System (MIDS) is an innovative clinical monitoring system developed to detect early signs of myocardial injury among COVID-19 patients, particularly those in Category 4 and Category 5 who are at higher risk of severe complications.
The system is designed to assist healthcare professionals in identifying cardiac abnormalities at an early stage, enabling prompt medical intervention and improving patient outcomes.
MIDS functions by continuously monitoring important clinical indicators associated with myocardial injury, such as cardiac biomarkers, electrocardiogram (ECG) changes, oxygen saturation levels, and heart rate patterns.
Through early detection and real-time monitoring, the system helps clinicians recognize potential cardiac complications before they become life-threatening.
COVID-19 infection is known to increase the risk of myocardial injury due to severe inflammation, hypoxia, cytokine storm, and cardiovascular stress. If left undetected, myocardial injury can rapidly progress to serious complications.
These complications include arrhythmia, heart failure, or sudden cardiac death. Therefore, early identification is crucial for timely treatment and prevention of mortality.
MIDS provides a proactive approach in patient management by supporting early diagnosis, facilitating immediate clinical decision-making, and improving the efficiency of monitoring critically ill COVID-19 patients.
The implementation of this system may contribute to better patient prognosis, reduced complications, and enhanced quality of healthcare delivery during critical care management.
Hover over each step to see the details.